Suzanne A. W. Fuqua, PhD, professor of medicine at Baylor College of Medicine, discusses the Y537 hotspot in breast cancer.
Suzanne A. W. Fuqua, PhD
Advertisement
Articles by Suzanne A. W. Fuqua, PhD
Suzanne A. W. Fuqua, PhD, professor of medicine, Baylor College of Medicine, says that it is an exciting time for the treatment of patients with metastatic breast cancer.
Suzanne A. W. Fuqua, PhD, professor of medicine, Baylor College of Medicine, talks about the interaction between estrogen receptors (ER) and androgen receptors (AR) in patients with breast cancer.
Suzanne A. W. Fuqua, PhD, professor of medicine at Baylor College of Medicine, discusses the androgen receptor in breast cancer.
Suzanne Fuqua, PhD, from the Baylor College of Medicine, on the Utilization of Predictive Biomarkers
Advertisement
Latest Updated Articles
Suzanne Fuqua on Utilizing Predictive BiomarkersPublished: August 21st 2012 | Updated:
- Suzanne A. W. Fuqua, PhD, on the Androgen Receptor
Published: July 18th 2013 | Updated:
Suzanne Fuqua on the Interaction Between ER and ARPublished: September 12th 2013 | Updated:
Suzanne Fuqua on Biopsying Metastatic TumorsPublished: October 18th 2013 | Updated:
Suzanne Fuqua Discusses the Y537 Hotspot in Breast CancerPublished: August 18th 2014 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
3
Multidisciplinary Breast Cancer Experts Outline Proactive Strategies for Managing Treatment-Related Toxicities: With Neil Iyengar, MD; Heather Moore, CPP, PharmD; and Sarah Donahue, MPH, NP
4
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
5